Biond Biologics
Sector:
Pharma/Biotech
Subsector:
Immunotherapies
Geography:
Israel
Regulatory status:
Clinical Trials
Back
Biond Biologics is a clinical-stage biotechnology company developing first-in-class immunotherapies targeting novel pathways across both the innate and adaptive immune systems. The company's pipeline includes clinical-stage oncology programs, alongside a growing portfolio of discovery and preclinical programs in immune-mediated diseases.